A detailed history of Forefront Analytics, LLC transactions in Geron Corp stock. As of the latest transaction made, Forefront Analytics, LLC holds 19,023 shares of GERN stock, worth $48,889. This represents 0.03% of its overall portfolio holdings.

Number of Shares
19,023
Previous 18,491 2.88%
Holding current value
$48,889
Previous $83,000 19.28%
% of portfolio
0.03%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$3.3 - $4.44 $1,755 - $2,362
532 Added 2.88%
19,023 $67,000
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $5,900 - $7,060
-1,415 Reduced 7.11%
18,491 $83,000
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $6,293 - $10,332
2,030 Added 11.36%
19,906 $84,000
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $18,270 - $35,913
-10,440 Reduced 36.87%
17,876 $58,000
Q4 2023

Feb 13, 2024

SELL
$1.74 - $2.31 $1,392 - $1,848
-800 Reduced 2.75%
28,316 $59,000
Q3 2023

Nov 07, 2023

BUY
$2.11 - $3.28 $30,014 - $46,658
14,225 Added 95.53%
29,116 $61,000
Q2 2023

Aug 11, 2023

SELL
$1.97 - $3.69 $25,001 - $46,829
-12,691 Reduced 46.01%
14,891 $47,000
Q1 2023

May 11, 2023

BUY
$2.14 - $3.4 $1,465 - $2,329
685 Added 2.55%
27,582 $59,000
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $18,901 - $22,532
9,311 Added 52.95%
26,897 $65,000
Q3 2022

Nov 14, 2022

SELL
$1.67 - $2.94 $28,640 - $50,421
-17,150 Reduced 49.37%
17,586 $44,000
Q2 2022

Aug 10, 2022

SELL
$1.19 - $1.65 $61,761 - $85,635
-51,900 Reduced 59.91%
34,736 $59,000
Q1 2022

May 09, 2022

BUY
$0.99 - $1.6 $2,079 - $3,360
2,100 Added 2.48%
86,636 $117,000
Q4 2021

Feb 11, 2022

BUY
$1.22 - $1.72 $2,684 - $3,784
2,200 Added 2.67%
84,536 $103,000
Q3 2021

Nov 15, 2021

BUY
$1.2 - $1.5 $7,020 - $8,775
5,850 Added 7.65%
82,336 $113,000
Q2 2021

Aug 10, 2021

BUY
$1.25 - $1.83 $6,985 - $10,226
5,588 Added 7.88%
76,486 $108,000
Q1 2021

May 13, 2021

BUY
$1.52 - $2.1 $16,298 - $22,518
10,723 Added 17.82%
70,898 $113,000
Q4 2020

Feb 12, 2021

SELL
$1.55 - $2.05 $5,820 - $7,697
-3,755 Reduced 5.87%
60,175 $97,000
Q3 2020

Nov 12, 2020

BUY
$1.59 - $2.19 $101,648 - $140,006
63,930 New
63,930 $111,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $971M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.